News
PAVM
3.960
-0.25%
-0.010
Weekly Report: what happened at PAVM last week (0907-0911)?
Weekly Report · 6d ago
PAVmed Launches New At-the-Market Equity Offering
TipRanks · 09/10 10:35
Weekly Report: what happened at PAVM last week (0831-0904)?
Weekly Report · 09/07 09:46
Weekly Report: what happened at PAVM last week (0824-0828)?
Weekly Report · 08/31 09:51
Nvidia To Rally Around 146%? Here Are 10 Top Analyst Forecasts For Thursday
Benzinga · 08/27 13:19
PAVmed price target raised to $57 from $56 at Ascendiant
TipRanks · 08/27 11:45
Weekly Report: what happened at PAVM last week (0817-0821)?
Weekly Report · 08/24 09:51
PAVmed Earnings Call: Progress Amid Liquidity Strain
TipRanks · 08/23 00:12
Weekly Report: what happened at PAVM last week (0810-0814)?
Weekly Report · 08/17 09:52
PAVmed reports Q2 adjusted EPS (27c) vs. ($1.40) last year
TipRanks · 08/16 13:31
PAVmed Maintained at Buy as Analyst Sees Long-Term Growth Upside; $16 Price Target Reaffirmed
TipRanks · 08/15 19:45
PAVmed Reports Q2 2026 Results and Operational Progress
TipRanks · 08/14 15:17
PAVmed Q2 2026 Earnings Call: Complete Transcript
Benzinga · 08/14 12:59
PAVmed GAAP EPS of $0.87
Seeking Alpha · 08/14 12:02
PAVmed Q2 Adj. EPS $(0.27) Beats $(0.58) Estimate, Sales $33.000K Miss $72.000K Estimate
Benzinga · 08/14 12:01
Press Release: PAVmed Provides Business Update -2-
Dow Jones · 08/14 12:00
Here are the major earnings before the open Friday
Seeking Alpha · 08/13 22:00
Pre-Market Earnings Report for August 14, 2026 : USAS, SGML, OTLK, STRR, PAVM, LFWD, CMCT, QNRX, ACXP
NASDAQ · 08/13 20:00
PAVmed Q2 2026 Earnings Preview
Seeking Alpha · 08/13 18:46
Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results
PR Newswire · 08/13 12:00
More
Webull provides a variety of real-time PAVM stock news. You can receive the latest news about Pavmed through multiple platforms. This information may help you make smarter investment decisions.
About PAVM
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates in the medical devices, diagnostics, and digital health sectors. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for early detection of esophageal precancer to prevent esophageal cancer deaths. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells. EsoGuard is a bisulfite-converted next-generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. Its other subsidiary, Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices.